UMMY20033 /Steroid Sparing Treatment/ Frank Passero
Basic Study Information
Purpose:Location: University of Rochester Medical Center
The purpose of this study is to determine the effects of daratumumab and lenalidomide
without steroids for treating patients with multiple myeloma.
Lead Researcher (Principal Investigator)
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search